This phenomenon was not observed in women treated with insulin-sensitizing metformin (Figure 3), which could also decrease glycation levels present in LDL, as it occurs in patients with T2DM [103], thereby allowing normal binding between LDLs and their receptors and then decreasing LDL levels in plasma. Here, INS is linked to type 2 diabetes mellitus.